HEPATOID ADENOCARCINOMA OF STOMACH
Clinical trials for HEPATOID ADENOCARCINOMA OF STOMACH explained in plain language.
Never miss a new study
Get alerted when new HEPATOID ADENOCARCINOMA OF STOMACH trials appear
Sign up with your email to follow new studies for HEPATOID ADENOCARCINOMA OF STOMACH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare stomach cancer: drug cocktail shows promise in early trial
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs and an immunotherapy drug for a rare and aggressive type of stomach cancer called hepatoid adenocarcinoma. About 30 people with locally advanced, HER2-negative cancer will receive the treatment before and after surgery. The goa…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for rare stomach cancer: Triple-Drug attack before surgery
Disease control Recruiting nowThis study tests a combination of three drugs (RC48, SOX, and Sindilizumab) given before and after surgery for a rare and aggressive stomach cancer called hepatoid adenocarcinoma. The goal is to see if this approach can shrink tumors and improve outcomes. About 30 participants wi…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 26, 2026 18:14 UTC